{{Rsnum
|rsid=2834072
|Chromosome=21
|position=33038156
|Orientation=plus
|GMAF=0.4403
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 24.8 | 54.0 | 21.2
| HCB | 48.9 | 40.9 | 10.2
| JPT | 48.7 | 41.6 | 9.7
| YRI | 17.1 | 44.5 | 38.4
| ASW | 24.6 | 52.6 | 22.8
| CHB | 48.9 | 40.9 | 10.2
| CHD | 45.0 | 50.5 | 4.6
| GIH | 34.7 | 42.6 | 22.8
| LWK | 19.1 | 46.4 | 34.5
| MEX | 15.5 | 67.2 | 17.2
| MKK | 35.9 | 50.0 | 14.1
| TSI | 37.3 | 50.0 | 12.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=19477230
|Title=Evidence that variation in the oligodendrocyte lineage transcription factor 2 (OLIG2) gene is associated with psychosis in Alzheimer's disease
}}

{{PMID|16891421|OA=1
}} Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}